Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ASCOF Lagundi
- Development stage
- Unknown
- Lead developer
- Pascual Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ASCOF Lagundi is an over-the-counter herbal medicine developed and manufactured by Pascual Laboratories in the Philippines. It is derived from the leaves of the lagundi plant (*Vitex negundo L.*), which are 100% organically grown on certified farms. Introduced in 1996, it was the first herbal medicine licensed by the Philippine Department of Science and Technology (DOST) and the Philippine Council for Health Research and Development (PCHRD). The product is indicated for the relief of cough associated with common colds and flu, as well as for the treatment of bronchospasm in acute bronchial asthma, chronic bronchitis, and other bronchopulmonary disorders. It exerts its therapeutic effects through bronchodilator, expectorant, and anti-inflammatory actions, serving as a natural alternative to synthetic cough and asthma medications.
- Brand names
- ASCOFASCOF LagundiASCOF Forte
- Other names
- Vitex negundoLagundi
Beyond the preview
Go deeper on ASCOF Lagundi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ASCOF Lagundi.